We confirmed the upregulation of PD-L1 in tumor cells (cytokeratin-14 positive) and non-tumor cells (cytokeratin-14 negative) by using immunofluorescence staining (Fig. 5B). This evidence concerns the gene KRT14 and neoplasm.